Abstract
In the present study, we evaluated the effects of the clinically approved antiepileptic drugs (AEDs) carbamazepine (CBZ) and phenytoin (PHT) on brainstem audiogenic seizures (AGS) and limbic seizures in Krushinsky-Molodkina (KM) audiogenic rats. To analyze AED effects on the standard AGS, KM rats received single intraperitoneal injection of CBZ (50 mg/kg), PHT (25 mg/kg), or vehicle before the single AGS stimulation. Other three groups of male and female KM rats were exposed to 14 daily AGS stimulations (audiogenic kindling), resulting in the stable development of limbic clonus, and on the next day, received the same injections before the 15th AGS stimulation. Naïve vehicle-treated KM rats were recruited as well as non-seizure control. The results showed that administration of CBZ and PHT significantly reduced the severity of the standard AGS in both experiments. Moreover, after the development of the limbic seizures, administration of both CBZ and PHT completely prevented the limbic clonus, and the effect on the brainstem component was more pronounced, than for standard AGS. In addition, the results showed that both AEDs decrease the activation of Ca2+ signaling processes and ERK1/2-dependent cascade in the hippocampus of kindled KM rats. Meanwhile, CBZ additionally suppressed seizure-induced increase in glutamate/GABA ratio in the hippocampus, while PHT specifically affected cyclic AMP-dependent signaling. Together with the previous results, the present data indicate that audiogenic kindling in KM rats is a valid approach to reproduce the development of limbic seizures, which can be used to investigate new strategies of epilepsy treatment.